How to Analyse an Alcobev Stock (P&A, Premiumisation)

In its December 2025 quarter, Radico Khaitan sold a record 9.75 million cases of IMFL, up 16.7% year-on-year — but the headline volume is not the story. Its Prestige & Above volume grew 25.9%, far faster than the overall book, lifting the premium mix sharply (Radico Q3 FY26 investor presentation). Gross margin came in at 46.9%, a 350 basis-point expansion year-on-year, and management broke down exactly where it came from: "Raw material accounted for 225 bps of gross margin" growth, the rest from selling a richer mix of bottles (Radico Q3 FY26 investor presentation). The company sold more liquor — and, more importantly, better liquor — and that richer mix is the entire game in alcobev. (Illustration of how to read the numbers, not a view on the stock.)

That distinction — volume versus mix — is what separates an alcobev analyst from someone reading the P&L. A spirits or beer company can grow revenue while its economics stagnate (if it just pushes more cheap cases), or grow revenue slowly while its economics transform (if every extra case is a premium one). Net sales, even volume, can mislead you, because the thing that actually moves margin is which cases you sold and what the state let you charge for them.

This is how to analyse an alcohol beverage (alcobev) stock the way a sector analyst does: the handful of mix-and-margin numbers that decide the outcome, where the important ones hide (almost always the investor deck and the concall, not the income statement), how to value a premiumisation story without overpaying for it, and the one risk that can erase a great operating quarter overnight — a state government changing the rules.

A boundary first: this guide does not model the legal and excise regime state by state — that is a specialist's full-time job, and it is precisely the variable an outside analyst controls least. What you can read is whether a company's mix, its cost structure, and its route-to-market discipline are built to compound through that uncertainty.

What actually drives the economics of an alcobev company?

Picture a restaurant that is told by the local council exactly how much it may charge for each dish, must buy its flour through a government-run depot, and needs a fresh licence in every town it wants to serve. It cannot win by raising prices at will. It can only win two ways: by getting customers to order the expensive dishes, and by buying its flour cheaper than rivals. That is an Indian alcobev company. The council is the state excise department; the flour is extra-neutral alcohol (ENA) and glass; the expensive dish is a premium brand.

Three consequences fall out of that picture, and they govern everything.

Premiumisation is the only pricing power that exists. Because most states control the retail price of liquor and revise it slowly, a company cannot simply hike its way to higher margin. It has to shift the mix — sell a larger share of Prestige-and-Above (P&A) brands that carry a structurally higher margin. Premiumisation is not a marketing slogan here; it is the substitute for the price increases the company is not allowed to take.

Gross margin is a commodity-and-glass story underneath the mix story. The two big input costs — ENA (the base spirit, linked to grain and molasses prices) and glass bottles (energy-linked) — are volatile and largely outside the company's control. A great premiumisation quarter can be masked by an ENA spike, and a benign-input quarter can flatter a stagnant mix. You have to separate the two, and the good companies tell you the split.

The state is the silent third partner in every bottle. Excise duty, route-to-market (whether the state sells through a government corporation or private trade), and licensing decide how much of each rupee the company keeps and whether it can even sell in a given market. A single state's policy change — Andhra Pradesh's route-to-market reform is the live example — can swing a company's volume and mix in one quarter.

Hold those three — mix, input cost, and the state — and the metrics below stop being a list and become a single story.

The metrics that matter — and where they hide

Here is the uncomfortable part for anyone used to reading a P&L: the numbers that decide an alcobev investment are mostly not on the income statement. P&A volume, premiumisation salience, gross-margin bridge, realisation per case, A&P spend as a share of sales — these live in the investor presentation and get unpacked on the concall. The income statement gives you net sales and operating profit; it does not tell you whether you sold more premium cases or just dumped cheap volume, and those two have opposite meanings.

Prestige & Above (P&A) volume and salience

P&A is the industry's name for the premium half of the portfolio — the brands above the cheap "regular" segment. Two numbers matter: P&A volume growth (is the premium engine running?) and P&A salience (what share of total volume or value is now premium?). It matters because P&A is where the margin lives — premiumisation in one number. Where to find it: never the income statement; it is a headline slide in the deck and a recurring concall topic. Radico's P&A category grew 25.9% in volume in Q3 FY26, lifting P&A to 49.6% of total own volume and 73.6% of total IMFL revenue (Radico Q3 FY26 investor presentation). Allied Blenders & Distillers (ABDL) pushed P&A salience to 48.5% in Q3 FY26 from 42% a year earlier, with P&A volume up 16.9% (ABDL Q3 FY26 concall). United Spirits sits at the structural extreme — P&A is already around 88.5% of net sales value (United Spirits FY25 results). What "good" looks like is salience rising several points a year while value growth runs ahead of volume growth — the sign that mix, not just cases, is doing the work.

Premiumisation mix (value growth vs volume growth)

The cleanest single tell of genuine premiumisation is the gap between value growth and volume growth. If a company's revenue grows faster than its cases, each case is getting richer; if volume outruns value, it is buying growth with cheap cases. Where to find it: the deck states both, side by side. Radico's Q3 FY26 P&A grew 25.9% by volume but 29.4% by value (Radico Q3 FY26 investor presentation) — value ahead of volume, premiumisation working. ABDL showed the same shape early in FY26: P&A volume up around 47% while P&A value share jumped to 55.8% of sales from 46.1% a year earlier (ABDL Q1 FY26 concall, figures as the company reported them). The trap is the reverse case — a company crowing about double-digit volume while value lags, which usually means a regular-segment, low-margin push dressed up as growth.

Gross margin — and the ENA-and-glass bridge

Gross margin (net sales minus material cost) is where the input-cost war shows up. It matters because the two big inputs — ENA and glass — are volatile, and a margin move can be either a mix win (durable) or an input swing (temporary). The good companies bridge it for you. Where to find it: the percentage is in the deck; the bridge — how much came from raw material versus mix — is in the concall and the deck notes, and it is the single most useful thing on the call. Radico spelled it out: of its 350 bps Q3 FY26 gross-margin expansion (to 46.9%), "Raw material accounted for 225 bps," the balance from premiumisation, and management flagged that it expects "the pricing scenario for ENA and grains will remain stable to benign in the near term" (Radico Q3 FY26 investor presentation). United Breweries (beer, so glass and barley dominate) ran gross margin around 42–43% through FY25 (UBL FY25 concall). ABDL, lower down the premium ladder, sat near 43% gross margin and is leaning on backward integration — its own ENA — to add roughly "300 basis points to EBITDA margin" from FY27 (ABDL Q1 FY26 concall). Read the bridge: a margin gain that is 225 bps raw material is a gift from the commodity cycle and can reverse; a gain from mix is the company's own work.

Realisation per case

The average net revenue the company earns per case of liquor sold — the alcobev version of "average selling price." It matters because, in a price-controlled industry, realisation rises mainly through mix and the occasional state price revision, so a steadily climbing realisation per case is premiumisation made visible at the unit level. Where to find it: the concall, quoted as a growth rate; sometimes the deck. ABDL reported realisation per case up 6.2% early in FY26 and 3.8% in the following quarter (ABDL Q1 and Q2 FY26 concalls); Radico's overall IMFL realisation rose 4.6% year-on-year in Q4 FY25 (Radico Q4 FY25 concall). Low single-digit realisation growth in a year with no state price hike is healthy — it is mix doing the lifting. Flat or falling realisation while volume grows is the cheap-case warning again.

A&P (advertising & promotion) spend as a share of sales

Liquor advertising is banned in India, so brands are built through surrogate advertising, on-trade visibility and trade promotion — and that spend, A&P (or A&SP), is the lifeblood of premiumisation. It matters because under-spending harvests today's brands at the cost of tomorrow's premiumisation, and over-spending without mix payoff just burns cash. Where to find it: the concall and deck, as a percentage of (usually IMFL or P&A) revenue. Radico guides A&SP "in the range of 6-8% of our IMFL revenues" and ran 6.9% in Q3 FY26, up from 5.5% a year earlier as it backed new premium launches (Radico Q3 FY26 investor presentation). ABDL, building premium brands from a lower base, runs A&P "roughly 4.5%, 5% of the P&A NSV" and has guided to raise it "75 basis to 100 basis points year-on-year for the next two or three years" (ABDL Q2 FY26 concall). The thing to watch is direction with intent: rising A&P behind rising P&A salience is investment; rising A&P with flat mix is a leak.

State excise and route-to-market exposure

Not a ratio but a structural read: how concentrated is the company in any one state, and is that state's route-to-market (government corporation versus private trade) shifting? It matters because a single state can make or break a quarter. Where to find it: the concall, usually in answer to an analyst question, and occasionally a state-mix slide. The live case is Andhra Pradesh — Radico noted that the "change in the route-to-market in Andhra Pradesh contributed to the regular volume growth to a large extent" in FY26 (Radico Q3 FY26 investor presentation). A company candid about its state concentration and the policy risks attached to it is doing you a favour; one that only ever reports a clean national aggregate is hiding the variable that matters most.

How do you value an alcobev company?

Alcobev does not have the violent earnings cycle of steel, so a P/E is at least usable here — but the multiple is almost entirely a premiumisation call, and that is where investors overpay.

The market awards a large P/E premium to companies further up the premium ladder, because P&A earnings are higher-margin, more brand-protected, and grow faster. United Spirits — around 88.5% P&A — trades far richer than a regular-heavy peer, and that is rational if the premium mix is durable. The error is paying a premiumisation multiple for a company whose mix is not actually shifting, or extrapolating a few benign-ENA quarters of margin expansion as if they were structural. A gross-margin gain that was 225 bps raw material (as Radico disclosed) does not deserve a re-rating; a gain from salience does.

So value it on two questions, not one multiple:

What is the through-cycle gross margin, stripped of the input swing? Use the company's own bridge to separate mix-driven margin (durable) from commodity-driven margin (cyclical), and value the durable part. A company whose margin only rose because ENA was cheap is borrowing earnings from the next ENA spike.

Is the premiumisation real and self-funding? P&A value growth running ahead of volume growth, salience climbing several points a year, A&P spend rising behind it, and realisation per case grinding up — that combination justifies a premium multiple. Any one of them alone does not. The owner's frame: don't ask "is the P/E low?" Ask "what share of this company's volume will be premium in five years, what gross margin does that mix earn at normal ENA prices, and am I paying for the mix it has or the mix it merely hopes for?"

A regulatory overlay sits on top of all of it: because one state's excise change can reset volume and margin, the alcobev multiple should carry a discount for policy risk that a comparable consumer-staples name does not. The swing factor in alcobev valuation is not demand — Indians keep drinking — it is the state.

A worked case: Radico Khaitan, said versus did

The cleanest way to feel why mix is the metric is to track one company's premiumisation guidance against what actually landed. Radico Khaitan spent FY25–FY26 telling investors a specific story: premium volume growth, margin expansion from mix, and a fast-growing luxury portfolio. The record is unusually checkable. (Illustration, not a view on the stock; figures as the company reported them.)

On margin, at the Q4 FY25 call management guided gross-margin gains "based on our product profile and premiumization" and an A&SP range of "7% to 8%" (Radico Q4 FY25 concall). The deliveries followed: gross margin moved from 43.5% in Q4 FY25 to 46.9% in Q3 FY26 (Radico investor presentations), with the company itself attributing the move to premiumisation plus benign raw material — and being honest that 225 of the latest 350 bps was raw material, not mix (Radico Q3 FY26 investor presentation). On the premium engine, the FY25 guidance of "15% plus" P&A volume growth was not just met but beaten — P&A volume grew 41% early in FY26 and 25.9% by Q3 FY26 (Radico Q1 and Q3 FY26 investor presentations).

The luxury sub-plot is the tidiest example of guidance kept. In FY25 the luxury-and-semi-luxury portfolio did ₹340 crore, growing 32%, and management guided to "surpass INR 500 crores in FY26" (Radico Q4 FY25 concall). By the year's close it reported "INR 475 crores in sales value for FY26" (Radico Q4 FY26 investor presentation) — a near-miss on the round number, but a portfolio that did grow strongly off the prior base. Alongside it, the company guided toward being "almost debt-free by FY27" and cut net debt by ₹329 crore during FY26 (Radico Q4 FY26 investor presentation) — guidance set and visibly tracking.

The point is not that management is infallible — the ₹500 crore luxury target landed at ₹475 crore, and "guidance" in this sector always rides on state policy the company doesn't control. The point is the texture: when a company can show value growth ahead of volume, a margin bridge it is willing to decompose honestly, and a debt-reduction path it is actually walking, you are watching real premiumisation rather than a story. You only see that pattern by tracking each commitment against the quarter it was made — which is the job of Promise Tracker, and the kind of thing no one reconstructs by re-reading four transcripts by hand.

Red flags specific to an alcobev company

• Volume growth running ahead of value growth. The company is buying growth with cheap regular cases and calling it momentum. Always read P&A value growth next to P&A volume growth.
• Margin expansion that is all raw material. A gross-margin jump driven by benign ENA and glass, not mix, will reverse on the next input spike. Demand the bridge; value only the mix portion.
• A&P cut to protect a quarter's profit. Trimming advertising flatters near-term EBITDA and starves the premiumisation that justifies the multiple. Watch A&P direction against P&A salience.
• Heavy concentration in one state with shifting policy. A company doing a large share of volume in a single state — especially one mid-route-to-market reform — carries a regulatory single-point-of-failure the aggregate numbers hide.
• Premium multiple on a mix that isn't moving. Paying a premiumisation P/E for a company whose P&A salience has been flat for two years is paying for a transformation that isn't happening.
• Realisation per case flat while volume grows. In a price-controlled market, stagnant per-case realisation alongside rising volume is the cheap-case problem showing up at the unit level.

Frequently asked questions

A repeatable workflow

1. Read mix, not just volume. P&A salience and P&A value growth versus volume growth, several quarters deep, from the deck.
2. Decompose the margin. Use the company's gross-margin bridge to separate mix-driven (durable) from ENA/glass-driven (cyclical) gains; value only the durable part.
3. Check realisation per case and A&P. Per-case realisation grinding up, A&P spend rising behind premiumisation — investment, not a leak.
4. Map the state risk. State concentration and any live route-to-market or excise change; treat single-state dependence as a structural flag.
5. Value on the mix, not the quarter. A premium P/E is earned by a moving mix at normal input prices, discounted for policy risk — not by a benign-ENA quarter.
6. Audit the guidance. Check premiumisation, margin and debt commitments against what actually happened next.

Inve's KPI Screener lines up P&A volume, premiumisation salience, gross margin and realisation per case across alcobev companies — value, trend and a data-confidence flag per number — so the deck-mining takes minutes, not an afternoon. For a sibling consumer read in a different shape, see how to analyse an FMCG company, where the lever is distribution reach rather than premium mix, or how to analyse a QSR restaurant company, where same-store sales play the role P&A salience plays here.

Where this lens can be wrong. The strongest case against everything above is that the variable this whole guide leans on least — state policy — is often the one that actually decides the outcome. You can read P&A salience, the margin bridge and realisation per case perfectly and still be blindsided by an excise hike, a prohibition wave, or a route-to-market change that resets volume and margin overnight, in a state you correctly identified as a risk but could not handicap. Reading the mix-and-margin numbers tells you whether a company is built to compound through the regulatory fog — a richer portfolio, self-funded A&P, its own ENA, low single-state dependence. It does not tell you what a state cabinet will decide next quarter, and the best-run premiumiser can have a great operating year erased by one notification. The honest claim is narrower than it looks: this analysis lowers your odds of overpaying for a stalled mix and raises your odds of owning a genuine premiumiser — it cannot price the political risk, and a great portfolio earns a poor return in a state that turns hostile.

The owner's question to sit with before buying any alcobev stock: five years out — not this quarter's gross margin — what share of this company's volume is premium, what does that mix earn at normal ENA and glass prices, and is the business diversified enough across states that no single excise decision can break it? If the answer leans on this year's benign input costs or one favourable state staying favourable forever, you have read the tailwind, not the business.

Related reading

• How to Analyse a Bank Stock (NIM, CASA, GNPA, ROA)
• How to Analyse a Building Products Company (Pipes, Tiles)
• How to Analyse a Cables and Wires Stock